Cargando…
Adjuvant or Salvage Radiation Therapy for Prostate Cancer after Prostatectomy: Current Status, Controversies and Perspectives
SIMPLE SUMMARY: The management of patients with biochemical recurrence after prostatectomy has undergone significant changes in recent years. Currently, close monitoring of prostate-specific antigen (PSA) with early salvage radiotherapy (RT) in case of recurrence is the standard of care based on sev...
Autores principales: | Terlizzi, Mario, Limkin, Elaine Johanna, Moukasse, Yasmina, Blanchard, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996903/ https://www.ncbi.nlm.nih.gov/pubmed/35406460 http://dx.doi.org/10.3390/cancers14071688 |
Ejemplares similares
-
Is single fraction the future of stereotactic body radiation therapy (SBRT)? A critical appraisal of the current literature
por: Terlizzi, M., et al.
Publicado: (2023) -
The Role of Salvage Radical Prostatectomy in Patients with Radiation-Resistant Prostate Cancer
por: Drobner, Jake, et al.
Publicado: (2023) -
Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death
por: Tilki, Derya, et al.
Publicado: (2022) -
A meta-analysis on the use of radiotherapy after prostatectomy: adjuvant versus early salvage radiation
por: Renzulli, Joseph F., et al.
Publicado: (2022) -
The role of lymph node dissection in salvage radical prostatectomy for patients with radiation recurrent prostate cancer
por: Quhal, Fahad, et al.
Publicado: (2021)